# | Title | Journal | Year | Citations |
---|
1 | Hydrogels in pharmaceutical formulations | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 3,290 |
2 | Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 3,078 |
3 | Improving drug solubility for oral delivery using solid dispersions | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 2,037 |
4 | Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 1,792 |
5 | Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy | European Journal of Pharmaceutics and Biopharmaceutics | 2015 | 1,278 |
6 | Polymeric micelles – a new generation of colloidal drug carriers | European Journal of Pharmaceutics and Biopharmaceutics | 1999 | 1,132 |
7 | In situ-forming hydrogels—review of temperature-sensitive systems | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 1,106 |
8 | Thermoresponsive hydrogels in biomedical applications | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 1,086 |
9 | Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 1,055 |
10 | Collagen – biomaterial for drug delivery1Dedicated to Professor Dr. Eberhard Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, on the occasion of his 70th birthday.1 | European Journal of Pharmaceutics and Biopharmaceutics | 1998 | 1,011 |
11 | A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes | European Journal of Pharmaceutics and Biopharmaceutics | 2007 | 967 |
12 | Polyethylenimine-based non-viral gene delivery systems | European Journal of Pharmaceutics and Biopharmaceutics | 2005 | 888 |
13 | Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation | European Journal of Pharmaceutics and Biopharmaceutics | 2006 | 888 |
14 | Nanoparticles for drug delivery: The need for precision in reporting particle size parameters | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 884 |
15 | Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 836 |
16 | Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism | European Journal of Pharmaceutics and Biopharmaceutics | 1998 | 765 |
17 | Chitosan-based drug delivery systems | European Journal of Pharmaceutics and Biopharmaceutics | 2012 | 755 |
18 | Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 678 |
19 | Recent advances on antimicrobial wound dressing: A review | European Journal of Pharmaceutics and Biopharmaceutics | 2018 | 650 |
20 | Mucoadhesive polymeric platforms for controlled drug delivery | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 625 |
21 | Melt extrusion: from process to drug delivery technology | European Journal of Pharmaceutics and Biopharmaceutics | 2002 | 604 |
22 | Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 588 |
23 | State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery | European Journal of Pharmaceutics and Biopharmaceutics | 2011 | 569 |
24 | Development and bioavailability assessment of ramipril nanoemulsion formulation | European Journal of Pharmaceutics and Biopharmaceutics | 2007 | 567 |
25 | HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 550 |
26 | Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 547 |
27 | Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review | European Journal of Pharmaceutics and Biopharmaceutics | 2013 | 531 |
28 | Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs | European Journal of Pharmaceutics and Biopharmaceutics | 2007 | 524 |
29 | Multifunctional and stimuli-sensitive pharmaceutical nanocarriers | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 524 |
30 | Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB) | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 516 |
31 | Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs | European Journal of Pharmaceutics and Biopharmaceutics | 2013 | 508 |
32 | Dendrimers as versatile platform in drug delivery applications | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 503 |
33 | Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration | European Journal of Pharmaceutics and Biopharmaceutics | 2011 | 493 |
34 | Nanoparticles – An efficient carrier for drug delivery into the hair follicles | European Journal of Pharmaceutics and Biopharmaceutics | 2007 | 488 |
35 | Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 486 |
36 | 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets | European Journal of Pharmaceutics and Biopharmaceutics | 2015 | 464 |
37 | Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages | European Journal of Pharmaceutics and Biopharmaceutics | 2011 | 461 |
38 | Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 459 |
39 | Passive skin penetration enhancement and its quantification in vitro | European Journal of Pharmaceutics and Biopharmaceutics | 2001 | 458 |
40 | Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 457 |
41 | Polysaccharide-decorated nanoparticles | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 441 |
42 | Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC) | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 433 |
43 | Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art | European Journal of Pharmaceutics and Biopharmaceutics | 2014 | 427 |
44 | Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase | European Journal of Pharmaceutics and Biopharmaceutics | 1999 | 418 |
45 | Chitosan as a starting material for wound healing applications | European Journal of Pharmaceutics and Biopharmaceutics | 2015 | 412 |
46 | Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation | European Journal of Pharmaceutics and Biopharmaceutics | 2007 | 410 |
47 | Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice | European Journal of Pharmaceutics and Biopharmaceutics | 2004 | 408 |
48 | Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs | European Journal of Pharmaceutics and Biopharmaceutics | 2000 | 395 |
49 | Current in vitro methods in nanoparticle risk assessment: Limitations and challenges | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 392 |
50 | Lipid nanoparticles for parenteral delivery of actives | European Journal of Pharmaceutics and Biopharmaceutics | 2009 | 388 |